FULCRUM THERAPEUTICS INC (FULC:NASDAQ)
$3.45 -0.1 (-2.8169%)
Analysed FULCRUM THERAPEUTICS INC (FULC:NASDAQ) News Sources
Fulcrum Therapeutics Announces Discontinuation of Pociredir Program in Sickle Cell Disease and Initiation of Strategic Review
01-06-2026
yahoo.com
Fulcrum Therapeutics Discontinues Sickle Cell Disease Program After US FDA Raises Malignancy Concerns
01-06-2026
yahoo.com
FULC Stock Slumps Nearly 50% After Hours As FDA Kills Only Clinical Program Over Cancer Risk
01-06-2026
stocktwits.com
Fulcrum exploring a potential sale after FDA sidelined its sickle cell drug
02-06-2026
biopharmadive.com
Meta Platforms upgraded, Okta downgraded: Wall Street's top analyst calls
02-06-2026
yahoo.com
This Biotech Stock Plunges 54%. Its Sickle Cell Drug Has ‘No Viable Path Forward.’
02-06-2026
yahoo.com
Why Did FULC, MVIS, HRTX Stocks Plunge To 52-Week Lows Today?
03-06-2026
stocktwits.com
FULC Stock Crashes as Cancer Risk Forces Its Only Drug Program's End
03-06-2026
yahoo.com
Fulcrum Therapeutics (FULC) Loses 51% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
05-06-2026
yahoo.com
A Look At Fulcrum Therapeutics (FULC) Valuation After Scrapping Lead Sickle Cell Drug And Restructuring
05-06-2026
yahoo.com
What is the current price of FULCRUM THERAPEUTICS INC (FULC:NASDAQ)?
The current price of FULCRUM THERAPEUTICS INC (FULC:NASDAQ) is $3.45.
FULCRUM THERAPEUTICS INC (FULC:NASDAQ) absolute price change since previous trading day?
The absolute price change of FULCRUM THERAPEUTICS INC (FULC:NASDAQ) since the previous trading day is $-0.1.
FULCRUM THERAPEUTICS INC (FULC:NASDAQ) percentage price change since previous trading day?
The percentage price change of FULCRUM THERAPEUTICS INC (FULC:NASDAQ) since the previous trading day is -2.8169%.
What is the most recent average sentiment score for FULCRUM THERAPEUTICS INC (FULC:NASDAQ)?
The most recent average sentiment score for FULCRUM THERAPEUTICS INC (FULC:NASDAQ) is 33 out of 100.
What is the most recent average sentiment for FULCRUM THERAPEUTICS INC (FULC:NASDAQ)?
The most recent sentiment for FULCRUM THERAPEUTICS INC (FULC:NASDAQ) is .
SEC-8K** Filing Available For FULCRUM THERAPEUTICS INC (FULC:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.